Clinical Trial Update: Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating anlotinib hydrochloride capsules combined with chemotherapy for squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Squamous Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN